BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12098845)

  • 1. Effect of bioadhesive polymers, sodium salicylate, polyoxyethylene-9-lauryl ether, and method of preparation on the relative hypoglycemia produced by insulin enteric-coated capsules in diabetic beagle dogs.
    Hosny EA; al-Shora HI; Elmazar MM
    Drug Dev Ind Pharm; 2002 May; 28(5):563-70. PubMed ID: 12098845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bio-adhesive polymers, sodium salicylate, polyoxyethylene-9-lauryl ether and method of preparation on the relative hypoglycemia produced by insulin enteric coated capsules in diabetic beagle dogs.
    Hosny EA; al-Shora HI; el-mazar MM
    Boll Chim Farm; 2002; 141(1):67-74. PubMed ID: 12064061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs.
    Hosny EA; Al-Shora HI; Elmazar MM
    Int J Pharm; 2002 Apr; 237(1-2):71-6. PubMed ID: 11955805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative hypoglycemic effect of insulin suppositories in diabetic beagle dogs: optimization of various concentrations of sodium salicylate and polyoxyethylene-9-lauryl ether.
    Hosny EA; Al-Shora HI; Elmazar MM
    Biol Pharm Bull; 2001 Nov; 24(11):1294-7. PubMed ID: 11725967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric-coated insulin capsules: a combination with or a replacement of oral hypoglycaemic drugs.
    Hosny EA; el-Bagory IM; al-Jenoobi FI
    Boll Chim Farm; 2002; 141(5):379-84. PubMed ID: 12481381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies.
    Hosny EA; Elkheshen SA; Saleh SI
    Boll Chim Farm; 2002; 141(3):210-7. PubMed ID: 12197420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemic effect of oral insulin in diabetic rabbits using pH-dependent coated capsules containing sodium salicylate without and with sodium cholate.
    Hosny EA; Ghilzai NM; al-Najar TA; Elmazar MM
    Drug Dev Ind Pharm; 1998 Mar; 24(3):307-11. PubMed ID: 9876590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different bile salts on the relative hypoglycemia of witepsol W35 suppositories containing insulin in diabetic Beagle dogs.
    Hosny EA; Al-Shora HI; Elmazar MM
    Drug Dev Ind Pharm; 2001 Sep; 27(8):837-45. PubMed ID: 11699836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of decrease in both postprandial blood glucose (PBG) and fasting blood glucose (FBG) levels in normal beagle dogs with nateglinide enteric coated granules and immediate release tablets.
    Makino C; Ninomiya N; Sakai H; Orita H; Okano A; Yabuki A
    Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):409-14. PubMed ID: 16595936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of oral insulin absorption in diabetic rabbits using pH-dependent coated capsules containing sodium cholate.
    Hosny EA; Ghilzai NM; Elmazar MM
    Pharm Acta Helv; 1997 Sep; 72(4):203-7. PubMed ID: 9372642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Part II: bioavailability in beagle dogs of nimodipine solid dispersions prepared by hot-melt extrusion.
    Zheng X; Yang R; Zhang Y; Wang Z; Tang X; Zheng L
    Drug Dev Ind Pharm; 2007 Jul; 33(7):783-9. PubMed ID: 17654027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
    Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
    Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds.
    Del Curto MD; Maroni A; Palugan L; Zema L; Gazzaniga A; Sangalli ME
    J Pharm Sci; 2011 Aug; 100(8):3251-3259. PubMed ID: 21465487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
    Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
    Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations.
    Tiwari D; Goldman D; Sause R; Madan PL
    AAPS PharmSci; 1999; 1(3):E13. PubMed ID: 11741209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral insulin in diabetic dogs.
    Saffran M; Field JB; Peña J; Jones RH; Okuda Y
    J Endocrinol; 1991 Nov; 131(2):267-78. PubMed ID: 1744572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.